149 related articles for article (PubMed ID: 9316818)
41. Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies.
Thompson JF; Siebert GA; Anissimov YG; Smithers BM; Doubrovsky A; Anderson CD; Roberts MS
Br J Cancer; 2001 Jul; 85(2):157-65. PubMed ID: 11461070
[TBL] [Abstract][Full Text] [Related]
42. Physiological pharmacokinetics of solutes in the isolated perfused rat hindlimb: characterization of the physiology with changing perfusate flow, protein content, and temperature using statistical moment analysis.
Wu ZY; Rivory LP; Roberts MS
J Pharmacokinet Biopharm; 1993 Dec; 21(6):653-88. PubMed ID: 8138892
[TBL] [Abstract][Full Text] [Related]
43. True versus mild hyperthermia during isolated hepatic perfusion: effects on melphalan pharmacokinetics and liver function.
Pilati P; Mocellin S; Rossi CR; Ori C; Innocente F; Scalerta R; Ceccherini M; Da Pian PP; Nitti D; Lise M
World J Surg; 2004 Aug; 28(8):775-81. PubMed ID: 15457357
[TBL] [Abstract][Full Text] [Related]
44. Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb.
Klaase JM; Kroon BB; Beijnen JH; van Slooten GW; van Dongen JA
Br J Cancer; 1994 Jul; 70(1):151-3. PubMed ID: 8018528
[TBL] [Abstract][Full Text] [Related]
45. Influence of protein binding and metabolic interconversion on the disposition of sulfisoxazole and its N4-acetyl metabolite by the isolated perfused rat kidney.
Bekersky I; Popick AC; Colburn WA
Drug Metab Dispos; 1984; 12(5):607-13. PubMed ID: 6149912
[TBL] [Abstract][Full Text] [Related]
46. Isolated lung perfusion with melphalan for the treatment of metastatic pulmonary sarcoma.
Nawata S; Abecasis N; Ross HM; Abolhoda A; Cheng H; Sachar KS; Burt ME
J Thorac Cardiovasc Surg; 1996 Dec; 112(6):1542-7; discussion 1547-8. PubMed ID: 8975846
[TBL] [Abstract][Full Text] [Related]
47. The role of hyperthermia in regional alkylating agent chemotherapy.
Abdel-Wahab OI; Grubbs E; Viglianti BL; Cheng TY; Ueno T; Ko S; Rabbani Z; Curtis S; Pruitt SK; Dewhirst MW; Tyler DS
Clin Cancer Res; 2004 Sep; 10(17):5919-29. PubMed ID: 15355925
[TBL] [Abstract][Full Text] [Related]
48. Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions.
de Wilt JH; Manusama ER; van Etten B; van Tiel ST; Jorna AS; Seynhaeve AL; ten Hagen TL; Eggermont AM
Br J Cancer; 2000 Nov; 83(9):1176-82. PubMed ID: 11027431
[TBL] [Abstract][Full Text] [Related]
49. Trace amounts of albumin protect against ischemia and reperfusion injury in isolated rat hearts.
Watts JA; Maiorano PC
J Mol Cell Cardiol; 1999 Sep; 31(9):1653-62. PubMed ID: 10471349
[TBL] [Abstract][Full Text] [Related]
50. Safety of autotransplants with high-dose melphalan in renal failure: a pharmacokinetic and toxicity study.
Tricot G; Alberts DS; Johnson C; Roe DJ; Dorr RT; Bracy D; Vesole DH; Jagannath S; Meyers R; Barlogie B
Clin Cancer Res; 1996 Jun; 2(6):947-52. PubMed ID: 9816255
[TBL] [Abstract][Full Text] [Related]
51. Synergistic antitumor activity of histamine plus melphalan in isolated limb perfusion: preclinical studies.
Brunstein F; Hoving S; Seynhaeve AL; van Tiel ST; Guetens G; de Bruijn EA; Eggermont AM; ten Hagen TL
J Natl Cancer Inst; 2004 Nov; 96(21):1603-10. PubMed ID: 15523089
[TBL] [Abstract][Full Text] [Related]
52. Variations in flow, duration, and concentration do not change the final lung concentration of melphalan after isolated lung perfusion in rats.
Romijn S; Hendriks JM; Van Putte BP; Guetens G; De Bruijn EA; Van Schil PE
Eur Surg Res; 2003; 35(1):50-3. PubMed ID: 12566788
[TBL] [Abstract][Full Text] [Related]
53. A physiological pharmacokinetic model for solute disposition in tissues below a topical below a topical application site.
Roberts MS; Cross SE
Pharm Res; 1999 Sep; 16(9):1392-8. PubMed ID: 10496655
[TBL] [Abstract][Full Text] [Related]
54. Assessment of hepatic integrity after ischemic preservation by isolated perfusion in vitro: the role of albumin.
Minor T; Manekeller S
Cryobiology; 2007 Apr; 54(2):188-95. PubMed ID: 17324395
[TBL] [Abstract][Full Text] [Related]
55. Serum factors other than albumin are needed for the maintenance of normal capillary permselectivity in rat hindlimb muscle.
Haraldsson B; Rippe B
Acta Physiol Scand; 1985 Apr; 123(4):427-36. PubMed ID: 3993401
[TBL] [Abstract][Full Text] [Related]
56. Hyaluronidase pretreatment produces selective melphalan enrichment in malignant melanoma implanted in nude mice.
Muckenschnabel I; Bernhardt G; Spruss T; Buschauer A
Cancer Chemother Pharmacol; 1996; 38(1):88-94. PubMed ID: 8603457
[TBL] [Abstract][Full Text] [Related]
57. Construction and validation of a microprocessor controlled extracorporal circuit in rats for the optimization of isolated limb perfusion.
Gürtler U; Fuchs P; Stangelmayer A; Bernhardt G; Buschauer A; Spruss T
Arch Pharm (Weinheim); 2004 Dec; 337(12):672-81. PubMed ID: 15597400
[TBL] [Abstract][Full Text] [Related]
58. Anterograde versus retrograde isolated lung perfusion with melphalan in the WAG-Rij rat.
Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G G; De Bruijn EA; Van Schil PE
Eur J Cardiothorac Surg; 2005 Jun; 27(6):1083-5. PubMed ID: 15896622
[TBL] [Abstract][Full Text] [Related]
59. Effect of indomethacin and N omega-nitro-L-arginine methyl ester on the pressure/flow relation in isolated perfused hindlimbs from pregnant and nonpregnant rats.
Ahokas RA; Friedman SA; Sibai BM
J Soc Gynecol Investig; 1997; 4(5):229-35. PubMed ID: 9360226
[TBL] [Abstract][Full Text] [Related]
60. Synthesis and in vivo biodisposition of [14C]-quaternary ammonium-melphalan conjugate, a potential cartilage-targeted alkylating drug.
Rapp M; Giraud I; Maurizis JC; Galmier MJ; Madelmont JC
Bioconjug Chem; 2003; 14(2):500-6. PubMed ID: 12643763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
